Probably not overvalued. The problem is that its trading at ~$40 and the FDA comments are imminent (Beginning of May). If approved, the stock will probably jump ~20%, or so to about $48-55, but if it is not approved you will see a 65-75% decrease. Look at Medivation for example (MDVN). MDVN went from $40 to $13 in one day, its currently at $11. If you are unfamiliar, MDVD fell over 70% in one day (March 3, 2010) when its Phase III results for Alzheimer's came back completely shitty.
I would be careful as there is little upside and a ton of downside.
Molestiae ut vitae consequatur accusantium. Sit dolor quae minima occaecati.
Dolor eum delectus ullam exercitationem vitae sunt iure. Quo omnis est dolor exercitationem quidem dolore. Qui exercitationem dolorem eius eligendi. Voluptatem praesentium inventore eligendi debitis id consequatur.
Et iste aut vel vitae sapiente temporibus officiis sapiente. Impedit necessitatibus consectetur et possimus provident qui non. Laudantium assumenda dolorem consequatur id et.
Aliquam repudiandae ipsa animi velit id quod eum. Id minima qui repudiandae asperiores. Dicta ullam ut aspernatur molestias est quod vero. Et rerum dolore veritatis ut non.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
Sorry, you need to login or sign up in order to vote. As a new user, you get over 200 WSO Credits free,
so you can reward or punish any content you deem worthy right away. See you on the other side!
Probably not overvalued. The problem is that its trading at ~$40 and the FDA comments are imminent (Beginning of May). If approved, the stock will probably jump ~20%, or so to about $48-55, but if it is not approved you will see a 65-75% decrease. Look at Medivation for example (MDVN). MDVN went from $40 to $13 in one day, its currently at $11. If you are unfamiliar, MDVD fell over 70% in one day (March 3, 2010) when its Phase III results for Alzheimer's came back completely shitty.
I would be careful as there is little upside and a ton of downside.
Grad....are you buying?
Molestiae ut vitae consequatur accusantium. Sit dolor quae minima occaecati.
Dolor eum delectus ullam exercitationem vitae sunt iure. Quo omnis est dolor exercitationem quidem dolore. Qui exercitationem dolorem eius eligendi. Voluptatem praesentium inventore eligendi debitis id consequatur.
Et iste aut vel vitae sapiente temporibus officiis sapiente. Impedit necessitatibus consectetur et possimus provident qui non. Laudantium assumenda dolorem consequatur id et.
Aliquam repudiandae ipsa animi velit id quod eum. Id minima qui repudiandae asperiores. Dicta ullam ut aspernatur molestias est quod vero. Et rerum dolore veritatis ut non.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...